RU2015128496A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2015128496A3 RU2015128496A3 RU2015128496A RU2015128496A RU2015128496A3 RU 2015128496 A3 RU2015128496 A3 RU 2015128496A3 RU 2015128496 A RU2015128496 A RU 2015128496A RU 2015128496 A RU2015128496 A RU 2015128496A RU 2015128496 A3 RU2015128496 A3 RU 2015128496A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3174MUM2013 | 2013-10-04 | ||
| IN3174MU2013 | 2013-10-04 | ||
| PCT/IB2014/065035 WO2015049665A1 (en) | 2013-10-04 | 2014-10-03 | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019104453A Division RU2799761C2 (ru) | 2013-10-04 | 2014-10-03 | Лечение аллергического ринита с использованием комбинации мометазона и олопатадина |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2015128496A RU2015128496A (ru) | 2017-11-13 |
| RU2015128496A3 true RU2015128496A3 (ru) | 2018-06-19 |
| RU2686670C2 RU2686670C2 (ru) | 2019-04-30 |
Family
ID=51982657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015128496A RU2686670C2 (ru) | 2013-10-04 | 2014-10-03 | Лечение аллергического ринита с использованием комбинации мометазона и олопатадина |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10646500B2 (ru) |
| EP (2) | EP4272839A3 (ru) |
| JP (3) | JP6419195B2 (ru) |
| CN (2) | CN112773808A (ru) |
| HK (1) | HK1215674A1 (ru) |
| MX (2) | MX2015009429A (ru) |
| MY (1) | MY176808A (ru) |
| PH (1) | PH12015502302B1 (ru) |
| RU (1) | RU2686670C2 (ru) |
| UA (1) | UA120587C2 (ru) |
| WO (1) | WO2015049665A1 (ru) |
| ZA (1) | ZA201504740B (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US9937189B2 (en) | 2013-09-13 | 2018-04-10 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| EP4272839A3 (en) * | 2013-10-04 | 2024-01-03 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10016443B2 (en) | 2013-10-04 | 2018-07-10 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10548907B2 (en) | 2013-10-04 | 2020-02-04 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10653661B2 (en) | 2013-10-04 | 2020-05-19 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US10758550B2 (en) | 2013-10-04 | 2020-09-01 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| US11679210B2 (en) | 2014-10-03 | 2023-06-20 | Glenmark Specialty S.A. | Dispensing device and pharmaceutical composition for the treatment of rhinitis |
| CN112870203B (zh) * | 2017-06-28 | 2022-09-23 | 格兰马克专业公司 | 用于治疗鼻炎的分配装置和药物组合物 |
| JP7391026B2 (ja) * | 2018-02-23 | 2023-12-04 | グレンマーク・スペシャルティー・エスエー | モメタゾン及びオロパタジンの組み合わせを用いた小児対象におけるアレルギー性鼻炎の治療 |
| JP7276099B2 (ja) | 2019-11-26 | 2023-05-18 | 株式会社鶴見製作所 | 無閉塞ポンプ |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8520662D0 (en) | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| US4923892A (en) | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| PE44995A1 (es) | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| WO2001026658A2 (en) | 1999-10-08 | 2001-04-19 | Schering Corporation | Topical nasal treatment using desloratadine |
| US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| KR20050074577A (ko) * | 2002-11-12 | 2005-07-18 | 알콘, 인코퍼레이티드 | 알레르기성 비염을 치료하기 위한 항알레르기제 및스테로이드의 용도 |
| US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| PL1814538T3 (pl) | 2004-11-24 | 2010-02-26 | Alcon Inc | Sposób dostarczania donosowego sprayu |
| CA2616515C (en) * | 2005-09-01 | 2014-09-23 | Biolipox Ab | Antihistamine- and corticosteroid- containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders |
| EP1968548A2 (en) | 2005-12-02 | 2008-09-17 | Elan Pharma International Limited | Mometasone compositions and methods of making and using the same |
| JP5185109B2 (ja) | 2006-04-21 | 2013-04-17 | 東興薬品工業株式会社 | スプレー用ゲルタイプ皮膚・粘膜付着型製剤およびそれを用いた投与システム |
| CN106038481A (zh) * | 2007-06-28 | 2016-10-26 | 锡德克斯药物公司 | 皮质类固醇水溶液的鼻部和眼部给药 |
| CN102159244A (zh) * | 2008-07-15 | 2011-08-17 | 先灵公司 | 包含减充血剂和皮质类固醇的鼻内组合物 |
| WO2010025236A1 (en) | 2008-08-27 | 2010-03-04 | Alexander Goldin | Composition and method for treating colds |
| US20110011392A1 (en) | 2009-07-17 | 2011-01-20 | Wall G Michael | Olopatadine nasal spray regimen for children |
| CN102078285A (zh) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶 |
| CN102078326A (zh) * | 2009-11-26 | 2011-06-01 | 天津金耀集团有限公司 | 含有聚维酮碘与糠酸莫米松的局部使用组合物 |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| CN103269687B (zh) | 2011-01-04 | 2016-09-14 | 伊斯塔制药公司 | 贝托斯汀组合物 |
| EP2912170A1 (en) | 2012-10-25 | 2015-09-02 | Novozymes A/S | Improved method for manual dish wash |
| KR20140081925A (ko) * | 2012-12-12 | 2014-07-02 | 한미약품 주식회사 | 코르티코스테로이드, 항히스타민제 및 스테비아를 포함하는 고미 차폐된 약학 제제 |
| EP3718533A1 (en) * | 2013-09-13 | 2020-10-07 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| US9370483B2 (en) | 2013-09-13 | 2016-06-21 | Glenmark Specialty S.A. | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine |
| EP4272839A3 (en) * | 2013-10-04 | 2024-01-03 | Glenmark Specialty S.A. | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
-
2014
- 2014-10-03 EP EP23198254.7A patent/EP4272839A3/en active Pending
- 2014-10-03 US US14/506,122 patent/US10646500B2/en active Active
- 2014-10-03 CN CN202110299649.8A patent/CN112773808A/zh active Pending
- 2014-10-03 WO PCT/IB2014/065035 patent/WO2015049665A1/en active Application Filing
- 2014-10-03 UA UAA201507124A patent/UA120587C2/uk unknown
- 2014-10-03 CN CN201480066538.0A patent/CN105792828A/zh active Pending
- 2014-10-03 JP JP2016546191A patent/JP6419195B2/ja active Active
- 2014-10-03 EP EP14802944.0A patent/EP2922553A1/en active Pending
- 2014-10-03 MY MYPI2015702416A patent/MY176808A/en unknown
- 2014-10-03 MX MX2015009429A patent/MX2015009429A/es active IP Right Grant
- 2014-10-03 RU RU2015128496A patent/RU2686670C2/ru active
-
2015
- 2015-07-01 ZA ZA2015/04740A patent/ZA201504740B/en unknown
- 2015-07-22 MX MX2020003035A patent/MX2020003035A/es unknown
- 2015-10-05 PH PH12015502302A patent/PH12015502302B1/en unknown
-
2016
- 2016-03-30 HK HK16103630.2A patent/HK1215674A1/zh unknown
-
2018
- 2018-04-11 JP JP2018076047A patent/JP6768733B2/ja active Active
-
2020
- 2020-02-21 JP JP2020028523A patent/JP2020097624A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN105792828A (zh) | 2016-07-20 |
| JP6419195B2 (ja) | 2018-11-07 |
| PH12015502302A1 (en) | 2016-02-15 |
| WO2015049665A1 (en) | 2015-04-09 |
| JP2018123157A (ja) | 2018-08-09 |
| UA120587C2 (uk) | 2020-01-10 |
| MX2020003035A (es) | 2020-07-22 |
| JP2020097624A (ja) | 2020-06-25 |
| PH12015502302B1 (en) | 2016-02-15 |
| MY176808A (en) | 2020-08-21 |
| JP6768733B2 (ja) | 2020-10-14 |
| MX2015009429A (es) | 2015-10-09 |
| US10646500B2 (en) | 2020-05-12 |
| RU2686670C2 (ru) | 2019-04-30 |
| EP4272839A3 (en) | 2024-01-03 |
| ZA201504740B (en) | 2016-10-26 |
| EP2922553A1 (en) | 2015-09-30 |
| CN112773808A (zh) | 2021-05-11 |
| EP4272839A2 (en) | 2023-11-08 |
| JP2016531949A (ja) | 2016-10-13 |
| HK1215674A1 (zh) | 2016-09-09 |
| US20150099725A1 (en) | 2015-04-09 |
| RU2015128496A (ru) | 2017-11-13 |
| RU2019104453A (ru) | 2019-03-28 |